ACAD
Companies
NASDAQ
Acadia Pharmaceuticals Inc.
Health Care
$22.80
+$4.61 (+25.12%)
Price Chart
Overview
About ACAD
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Market Cap
$2.5B
Volume
35.2M
Avg. Volume
38.8M
P/E Ratio
18.280487
Dividend Yield
0.00%
Employees
623.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.93
Moderate Correlation
Volatility
High (0.48)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ACAD shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$2.5B
Volume35.2M
P/E Ratio18.28
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 27, 2025Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025